Reports and Briefs on Pharmaceuticals

Published within

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

Type Product title / description Pub Price
Report
Report

Orphan Drug Trends

Datamonitor’s report Orphan Drug Trends provides an overview of orphan drug regulations in the major pharmaceutical markets, including pricing and reimbursement issues and an analysis of Big Pharma’s growing interest in orphan drugs.

Published By Datamonitor
25 Nov 2011 $2800
Buy
Report
Report

Emerging Technologies: Stem cells

This report provides an insight into the current stem cell pipeline and introduces key companies engaged in this high-risk but potentially high-return sector.

Published By Datamonitor
28 Nov 2011 $2800
Buy
Report
Report

Novartis AG: PharmaVitae Report

Analysis of Novartis's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
30 Nov 2011 $2800
Buy
Report
Report

Warner-Chilcott Plc: PharmaVitae Report

Analysis of Warner-Chilcott's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
30 Nov 2011 $2800
Buy
Report
Report

Pharma Company Outlook to 2016

Analysis of the outlook for all of the company's covered by Datamonitor's PharmaVitae team through to 2016, identifying key strategic themes and looking at sales performance by company, lifecycle stage, therapy area, and disease

Published By Datamonitor
07 Dec 2011 $2800
Buy
Report
Report

Molecular Diagnostics: Key Players

The report identifies the leading players that are active in the molecular diagnostic market, evaluating trends in corporate strategy and discussing the impact of key recent licensing deals. Key technologies from each player will also be profiled.

Published By Datamonitor
07 Dec 2011 $1520
Buy
Report
Report

Biosimilars: Regulatory Update

Datamonitor’s report Biosimilars: Regulatory Update provides analysis on key developments in biosimilar regulations globally. It includes an overview of the background behind these events and popular strategic responses.

Published By Datamonitor
08 Dec 2011 $1520
Buy
Report
Report

Biosimilars: Pipeline Trends

The report provides an overview of biosimilar and copy-biologic product landscape, split by marketed and pipeline products, target therapy areas and indications, geography, and drug developers.

Published By Datamonitor
09 Dec 2011 $2800
Buy
Report
Report

Allergan Inc.: PharmaVitae Report

Analysis of Allergan's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
09 Dec 2011 $2800
Buy
Report
Report

US Generics Overview

Sales of generic products in the US have historically grown at an impressive rate. However, the market has now reached a turning point: while considerable scope for growth remains, the number of new brands becoming available to genericize is slowing.

Published By Datamonitor
09 Dec 2011 $2800
Buy

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

No help is available.